Global Pharmacogenomics Services Market Research Report 2023(Status and Outlook)
- Published Date: 2023-08-20
- Report ID: 146602
- Pages: 250
-
Format:
Report Overview
Prudent Markets latest report provides a deep insight into the global Pharmacogenomics Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmacogenomics Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmacogenomics Services market in any manner.
Global Pharmacogenomics Services Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Admera Health, LLC
Mesa Laboratories, Inc.
Dynamic DNA Laboratories
F. Hoffmann-La Roche Ltd.
GeneOmbio Technologies Pvt Ltd.
Exact Sciences Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OmeCare
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Precipio
23andMe, Inc.
OneOme, LLC
DiaCarta, Inc.
OPKO Health
Market Segmentation (by Type)
Genotyping
SNP Identification
Pharmacogenetic Testing
Others
Market Segmentation (by Application)
Oncology
Infectious Diseases
Psychiatry
Cardiovascular
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmacogenomics Services Market
Overview of the regional outlook of the Pharmacogenomics Services Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacogenomics Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmacogenomics Services
1.2 Key Market Segments
1.2.1 Pharmacogenomics Services Segment by Type
1.2.2 Pharmacogenomics Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmacogenomics Services Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmacogenomics Services Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Pharmacogenomics Services Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmacogenomics Services Market Competitive Landscape
3.1 Global Pharmacogenomics Services Sales by Manufacturers (2018-2023)
3.2 Global Pharmacogenomics Services Revenue Market Share by Manufacturers (2018-2023)
3.3 Pharmacogenomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmacogenomics Services Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Pharmacogenomics Services Sales Sites, Area Served, Product Type
3.6 Pharmacogenomics Services Market Competitive Situation and Trends
3.6.1 Pharmacogenomics Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmacogenomics Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmacogenomics Services Industry Chain Analysis
4.1 Pharmacogenomics Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmacogenomics Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmacogenomics Services Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacogenomics Services Sales Market Share by Type (2018-2023)
6.3 Global Pharmacogenomics Services Market Size Market Share by Type (2018-2023)
6.4 Global Pharmacogenomics Services Price by Type (2018-2023)
7 Pharmacogenomics Services Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacogenomics Services Market Sales by Application (2018-2023)
7.3 Global Pharmacogenomics Services Market Size (M USD) by Application (2018-2023)
7.4 Global Pharmacogenomics Services Sales Growth Rate by Application (2018-2023)
8 Pharmacogenomics Services Market Segmentation by Region
8.1 Global Pharmacogenomics Services Sales by Region
8.1.1 Global Pharmacogenomics Services Sales by Region
8.1.2 Global Pharmacogenomics Services Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmacogenomics Services Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmacogenomics Services Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmacogenomics Services Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmacogenomics Services Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmacogenomics Services Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Pharmacogenomics Services Basic Information
9.1.2 Abbott Laboratories Pharmacogenomics Services Product Overview
9.1.3 Abbott Laboratories Pharmacogenomics Services Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Pharmacogenomics Services SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Admera Health, LLC
9.2.1 Admera Health, LLC Pharmacogenomics Services Basic Information
9.2.2 Admera Health, LLC Pharmacogenomics Services Product Overview
9.2.3 Admera Health, LLC Pharmacogenomics Services Product Market Performance
9.2.4 Admera Health, LLC Business Overview
9.2.5 Admera Health, LLC Pharmacogenomics Services SWOT Analysis
9.2.6 Admera Health, LLC Recent Developments
9.3 Mesa Laboratories, Inc.
9.3.1 Mesa Laboratories, Inc. Pharmacogenomics Services Basic Information
9.3.2 Mesa Laboratories, Inc. Pharmacogenomics Services Product Overview
9.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Product Market Performance
9.3.4 Mesa Laboratories, Inc. Business Overview
9.3.5 Mesa Laboratories, Inc. Pharmacogenomics Services SWOT Analysis
9.3.6 Mesa Laboratories, Inc. Recent Developments
9.4 Dynamic DNA Laboratories
9.4.1 Dynamic DNA Laboratories Pharmacogenomics Services Basic Information
9.4.2 Dynamic DNA Laboratories Pharmacogenomics Services Product Overview
9.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Product Market Performance
9.4.4 Dynamic DNA Laboratories Business Overview
9.4.5 Dynamic DNA Laboratories Pharmacogenomics Services SWOT Analysis
9.4.6 Dynamic DNA Laboratories Recent Developments
9.5 F. Hoffmann-La Roche Ltd.
9.5.1 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Basic Information
9.5.2 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Overview
9.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Market Performance
9.5.4 F. Hoffmann-La Roche Ltd. Business Overview
9.5.5 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services SWOT Analysis
9.5.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.6 GeneOmbio Technologies Pvt Ltd.
9.6.1 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Basic Information
9.6.2 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Overview
9.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Market Performance
9.6.4 GeneOmbio Technologies Pvt Ltd. Business Overview
9.6.5 GeneOmbio Technologies Pvt Ltd. Recent Developments
9.7 Exact Sciences Corporation
9.7.1 Exact Sciences Corporation Pharmacogenomics Services Basic Information
9.7.2 Exact Sciences Corporation Pharmacogenomics Services Product Overview
9.7.3 Exact Sciences Corporation Pharmacogenomics Services Product Market Performance
9.7.4 Exact Sciences Corporation Business Overview
9.7.5 Exact Sciences Corporation Recent Developments
9.8 Illumina, Inc.
9.8.1 Illumina, Inc. Pharmacogenomics Services Basic Information
9.8.2 Illumina, Inc. Pharmacogenomics Services Product Overview
9.8.3 Illumina, Inc. Pharmacogenomics Services Product Market Performance
9.8.4 Illumina, Inc. Business Overview
9.8.5 Illumina, Inc. Recent Developments
9.9 Laboratory Corporation of America Holdings
9.9.1 Laboratory Corporation of America Holdings Pharmacogenomics Services Basic Information
9.9.2 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Overview
9.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Market Performance
9.9.4 Laboratory Corporation of America Holdings Business Overview
9.9.5 Laboratory Corporation of America Holdings Recent Developments
9.10 Myriad Genetics, Inc.
9.10.1 Myriad Genetics, Inc. Pharmacogenomics Services Basic Information
9.10.2 Myriad Genetics, Inc. Pharmacogenomics Services Product Overview
9.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Product Market Performance
9.10.4 Myriad Genetics, Inc. Business Overview
9.10.5 Myriad Genetics, Inc. Recent Developments
9.11 OmeCare
9.11.1 OmeCare Pharmacogenomics Services Basic Information
9.11.2 OmeCare Pharmacogenomics Services Product Overview
9.11.3 OmeCare Pharmacogenomics Services Product Market Performance
9.11.4 OmeCare Business Overview
9.11.5 OmeCare Recent Developments
9.12 QIAGEN N.V.
9.12.1 QIAGEN N.V. Pharmacogenomics Services Basic Information
9.12.2 QIAGEN N.V. Pharmacogenomics Services Product Overview
9.12.3 QIAGEN N.V. Pharmacogenomics Services Product Market Performance
9.12.4 QIAGEN N.V. Business Overview
9.12.5 QIAGEN N.V. Recent Developments
9.13 Quest Diagnostics Incorporated
9.13.1 Quest Diagnostics Incorporated Pharmacogenomics Services Basic Information
9.13.2 Quest Diagnostics Incorporated Pharmacogenomics Services Product Overview
9.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Product Market Performance
9.13.4 Quest Diagnostics Incorporated Business Overview
9.13.5 Quest Diagnostics Incorporated Recent Developments
9.14 Thermo Fisher Scientific Inc.
9.14.1 Thermo Fisher Scientific Inc. Pharmacogenomics Services Basic Information
9.14.2 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Overview
9.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Market Performance
9.14.4 Thermo Fisher Scientific Inc. Business Overview
9.14.5 Thermo Fisher Scientific Inc. Recent Developments
9.15 Precipio
9.15.1 Precipio Pharmacogenomics Services Basic Information
9.15.2 Precipio Pharmacogenomics Services Product Overview
9.15.3 Precipio Pharmacogenomics Services Product Market Performance
9.15.4 Precipio Business Overview
9.15.5 Precipio Recent Developments
9.16 23andMe, Inc.
9.16.1 23andMe, Inc. Pharmacogenomics Services Basic Information
9.16.2 23andMe, Inc. Pharmacogenomics Services Product Overview
9.16.3 23andMe, Inc. Pharmacogenomics Services Product Market Performance
9.16.4 23andMe, Inc. Business Overview
9.16.5 23andMe, Inc. Recent Developments
9.17 OneOme, LLC
9.17.1 OneOme, LLC Pharmacogenomics Services Basic Information
9.17.2 OneOme, LLC Pharmacogenomics Services Product Overview
9.17.3 OneOme, LLC Pharmacogenomics Services Product Market Performance
9.17.4 OneOme, LLC Business Overview
9.17.5 OneOme, LLC Recent Developments
9.18 DiaCarta, Inc.
9.18.1 DiaCarta, Inc. Pharmacogenomics Services Basic Information
9.18.2 DiaCarta, Inc. Pharmacogenomics Services Product Overview
9.18.3 DiaCarta, Inc. Pharmacogenomics Services Product Market Performance
9.18.4 DiaCarta, Inc. Business Overview
9.18.5 DiaCarta, Inc. Recent Developments
9.19 OPKO Health
9.19.1 OPKO Health Pharmacogenomics Services Basic Information
9.19.2 OPKO Health Pharmacogenomics Services Product Overview
9.19.3 OPKO Health Pharmacogenomics Services Product Market Performance
9.19.4 OPKO Health Business Overview
9.19.5 OPKO Health Recent Developments
10 Pharmacogenomics Services Market Forecast by Region
10.1 Global Pharmacogenomics Services Market Size Forecast
10.2 Global Pharmacogenomics Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmacogenomics Services Market Size Forecast by Country
10.2.3 Asia Pacific Pharmacogenomics Services Market Size Forecast by Region
10.2.4 South America Pharmacogenomics Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmacogenomics Services by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Pharmacogenomics Services Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Pharmacogenomics Services by Type (2024-2029)
11.1.2 Global Pharmacogenomics Services Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Pharmacogenomics Services by Type (2024-2029)
11.2 Global Pharmacogenomics Services Market Forecast by Application (2024-2029)
11.2.1 Global Pharmacogenomics Services Sales (K Units) Forecast by Application
11.2.2 Global Pharmacogenomics Services Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
